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Abstract 
Myocardlal calcium-independent phospholipase A, (PLA,) activity is mediated by a 400 kDa catalytic complex comprised of a tetramer of 
ohosnhofructokinase (PFK) and a 40 kDa catalytic subunit [1,2]. During myocardial ischemia. calcium-independent PLA2 activity rapidly and 
ieveriibly translocates‘from’the cytosol to a membrane-associated compartment where it has been implicated as a mediator of ischemic damage [3,4]. 
Herein we demonstrate that the majority of both PFK mass and activity is translocated from the cytosol to a membrane-associated compartment 
prior to the onset of irreversible myocytic injury and that translocated PFK is catalytically inactive while membrane-associated. Furthermore, 
reperfusion of ischemic myocardium, or treatment of membranes derived from ischemic myocardium with ATP results in the conversion of both 
PFK mass and activity from its membrane-associated state to a soluble, catalytically-competent form. Collectively, these studies demonstrate that 
the concomitant changes in glycolysis and phospholipid hydrolysis during early myocardial ischemia result, at least in part, from the translocation 
of a common regulatory polypeptide critical in both processes. 
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1. Introduction 
Although alterations in glycolytic flux during the evo- 
lution of myocardial ischemia are multifactorial in na- 
ture, the allosteric modulation of phosphofructokinase 
(PFK) activity by P, and ATP is the predominant mech- 
anism underlying the regulation of glycolysis during 
early myocardial ischemia [5-91. Previous work has dem- 
onstrated the close temporal association between the 
onset of myocardial &hernia, increases in glycolytic flux 
and accelerated phospholipid hydrolysis [lo-141. Sub- 
stantial evidence has now been accrued implicating the 
activation and translocation of a calcium-independent 
PLA, as the enzymic mechanism responsible for the ac- 
celerated hydrolysis of critical myocardial membrane 
constituents which results in ischemic membrane dys- 
function [3,4]. In myocardium, calcium-independent 
PLA, activity is catalyzed by a 400 kDa catalytic com- 
plex comprised of a tetrameric PFK-like regulatory 
polypeptide and a 40 kDa catalytic element [1,2,15]. The 
demonstration that a common polypeptide (i.e. PFK) is 
critical to both glycolysis and phospholipolysis has sug- 
gested that a unifying molecular mechanism may be re- 
sponsible for the coordinate changes in glycolytic flux 
and phospholipid hydrolysis during early myocardial is- 
chemia [ 11. 
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Several studies have indirectly demonstrated that 
some glycolytic enzymes translocate to membrane-asso- 
ciated subcellular compartments during the evolution of 
the ischemic process, but definitive evidence demonstrat- 
ing alterations in membrane-associated protein mass of 
specific glycolytic constituents has not yet been presented 
[&l&18]. To investigate the temporal course of the 
translocation of PFK during the evolution of ischemic 
injury, we utilized an immunoaffinity purified, mono- 
specific antibody directed against PFK to identify is- 
chemia-induced alterations in the subcellular compart- 
mentation of PFK mass and activity. We now report that 
PFK, the enzyme mediating the rate-determining step in 
anaerobic glycolysis, undergoes a rapid and reversible 
translocation to a membrane fraction during myocardial 
ischemia where it remains catalytically inactive until it is 
released by reperfusion of ischemic myocardium. 
2. Materials and methods 
2. I. Langendorff perfusion of rabbit hearts 
Control and ischemic rabbit hearts were perfused retrograde through 
the aorta in the Langendorff mode as previously described [3,4]. After 
a 10 min pre-equilibration interval, the hearts were rendered globally 
ischemic (zero flow), perfused continuously, or, following a 15 min 
global ischemic episode, reperfused for the indicated times. Perfusions 
were terminated by the excision of ventricular myocardium which was 
rapidly homogenized in 10 mM Tris-HCl, 2 mM EDTA, 1 mM DTT, 
pH 8.0 at 4°C utilizing a polytron apparatus. The supematant and 
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particulate fractions were separated by centrifugation at 24,000 x g,,, 
for 20 min as previously described [8]. The resultant 24.000 x g,,, pellet 
was resuspended in buffer (10 mM Tris-HCI, 50 mM MgSO,. 5 mM 
DTT. 0.5 mM ATP. pH 8.0) at a concentration of 0.3 mg/ml. 
1.2. Immunological techniques 
Chicken IgY affinity-purified monospecific antibody directed agamst 
rabbit skeletal muscle phosphofructokinase was prepared as previously 
described [I]. Western blots were performed utilizing 10% SDS-poly- 
acrylamide gels employing established procedures [l, 191. To facihtate 
comparisons of the mass of PFK in the soluble and particulate frac- 
tions, microsomes were resuspended in a volume of homogenization 
buffer equal to that from which they were derived so that the intensity 
of the 85 kDa immunoreactive band in cytosol and microsomes is 
directly comparable to the amount of total mass present in each frac- 
tlon. 
2.3. Miscellaneous procedures and source of materiuls 
PFK activity was measured using a spectrophotometric assay as 
previously described [20]. A Bio-Rad protein assay kit was used to 
measure protein content according to the manufacturer’s instructions. 
Most reagents were purchased from Sigma. 
3. Results 
3.1. Translocation of phosphofructokinase during 
myocardial schemia 
In control hearts, the overwhelming majority of PFK 
mass and activity was present in the cytosolic compart- 
ment (Fig. 1). After only 5 min of myocardial ischemia, 
translocation of phosphofructokinase from the cytosolic 
to a membrane-associated fraction was manifest (Fig. 1). 
After 15 min of ischemia, the majority of PFK mass was 
present in a membrane-associated fraction which was 
accompanied, pari passu, by a decrease in the mass of 
PFK immunoreactive material in the cytosolic fraction. 
Although large amounts of PFK immunoreactive mate- 
rial were present in the membrane-associated fraction, it 
was catalytically incompetent until released by ATP (Fig. 
2). Since irreversible cellular injury is not manifest until 
after 30 min of acute myocardial ischemia in this model 
(vide infra), these results demonstrate that the transloca- 
tion of PFK from the cytosolic fraction to a membrane- 
associated fraction precedes myocytic cellular necrosis. 
Reversibility is an essential component of biologically 
important regulatory processes. Accordingly, we exam- 
ined the reversibility of the association of PFK with the 
membrane-associated fraction after reperfusion of glob- 
ally ischemic myocardium. In independent experiments, 
the majority of PFK immunoreactive material in control 
myocardium was again present in the soluble fraction, 
while that present after 15 min of myocardial ischemia 
was predominantly membrane-associated (lanes 1 and 2, 
Fig. 3). Reperfusion of myocardium rendered ischemic 
for 15 min resulted in the translocation of PFK in the 
particulate fraction to the cytosolic compartment (lanes 
3 and 4, Fig. 3). Collectively, these results demonstrate 
the rapid and reversible translocation of PFK from my- 
ocardial cytosol to a membrane-associated fraction 
where it is catalytically incompetent until released by 
reperfusion. 
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Fig. 1. Rabbit hearts were perfused retrograde m the Langendorff mode 
as described in section 2. After a 10 min equihbration period, the hearts 
were rendered globally lschemic for 0 (control), 2, 5, 15, 30 or 60 min 
(panels A and B) prior to preparation of the 24,000 x g,,, supernatants 
and pellets for analysis by Western blot with affinity-purified anti-PFK 
antibody. To facilitate direct comparisons. pellets from centrifugation 
were resuspended in a volume of homogenization buffer equal to that 
from which they were derived as described in section 2. A single 85 kDa 
immunoreactive band was present. The majority of the immunoreactive 
PFK mass was present in the 24,000 x g,,, supernatant (panel A: 0. 2. 
5 min) which decreased m intensity with increasing durations of is- 
chemia (panel A; 15,30,60 min). The 85 kDa immunoreactive band was 
present in low amounts in the 24,000 x g,,, pellet at early time points 
(panel B; 0,2,5 mm) and increased with the duration of ischemia (panel 
B: 15, 30, 60 mm). 
4. Discussion 
Although the precise biochemical mechanisms mediat- 
ing the alterations of glycolytic flux during anaerobic 
metabolism are not known in exact molecular detail, the 
possibility that glycolytic enzymes associate as a complex 
and translocate to membrane-associated subcellular 
fractions and contribute to the modulation of glycolytic 
flux has received substantial attention [6-8,16-181. For 
example, ‘delay-dissected’ (i.e. 1 h postmortem) sheep 
heart PFK activity is associated with the particulate frac- 
tion, while PFK activity in fresh sheep hearts is present 
in the soluble fraction [8]. Aldolase also undergoes a 
similar subcellular redistribution in perfused rat hearts 
during ischemia and/or anoxia [7]. 
Recently, we have shown that myocardial calcium- 
independent PLA, activity is mediated by a 400 kDa 
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Fig. 2. PFK activity assays were performed spectrophotometrically 
utilizing either the 24,000 x g,,,,, supernatant or resuspended pellets 
obtained after homogenization of perfused hearts as described in Fig. 
1 (0 (control) or 2, 5, 15. 30,60 min of ischemia). Soluble PFK activity 
(supernatant) decreased between 5 and 15 min, and reached a minimum 
(i.e. no measurable activity) at 30 min. PFK activity in the pellet (as- 
sessed after its desorbtion from the membrane mto the supematant 
after Mg’+-ATP treatment), increased between 5 and 30 min and the 
Mg2+-ATP released particulate PFK activity reached its maximum be- 
tween 30 and 60 min. 
complex comprised of catalytic (40 kDa) and regulatory 
(PFK isoform) polypeptides [1,2,15]. Since the regula- 
tory polypeptide of the calcium-independent PLA, cata- 
lytic complex is an isoform of PFK, we hypothesized that 
the translocation of PFK during the ischemic process 
could facilitate the delivery of the 40 kDa catalytic entity 
to specific membrane compartments which serve as sub- 
strates for calcium-independent PLA,. Herein we dem- 
onstrate that both PFK protein mass and activity are 
translocated from the cytosol to a membrane-associated 
compartment with a time course that was similar to the 
translocation of the ~lcium-inde~ndent PLA, activity 
during the evolution of ischemic injury [3,4]. Further- 
more, the reversible translocation of PFK mass and ac- 
tivity from the particulate to soluble fractions after 
reperfusion parallels the attenuation of membrane-asso- 
ciated PLA, activity induced by reperfusion of ischemic 
myocardium. Thus, through the direct physical interac- 
tion of key components in sugar and lipid metabofism 
(i.e. PFK and PLA,), glycolysis and phospholipolysis 
21.5 
can be coordinately regulated utilizing the chemical sen- 
sory machinery inherent in the structure of PFK. 
Collectively, these results demonstrate the rapid and 
reversible translocation of PFK from a soluble to a par- 
ticulate fraction during ischemia that follows a temporal 
course which is indistinguishable from that of the 
translocation of calcium-independent PLAz activity. 
While the chemical modification(s) of PFK and/or PLA2 
structure underlying the translocation of the PLA, cata- 
lytic complex remain to be precisely defined, these find- 
ings further substantiate the fundamental interrelation- 
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Fig. 3. Rabbit hearts were perfused utilizing a Langendorff mode1 as 
described in section 2. After a 10 min equilibration period, hearts were 
rendered globally ischemic for 0 or 15 min intervals without reperfusion 
(panel A and B; O/O, 15/O), or rendered globally ischemic for 15 min 
followed by 15 or 45 min period of reperfusion (panel A and B; 15/15 
and 15/45, respectively). Control hearts were perfused for 30 or 60 min 
at normal flow rates (panel A and B; 30 and 60 min, respectively). After 
the indicated periods of perfusion and/or reperfusion, the 24,000 x g,,,,, 
supematant and pellets were solubilized in SDS buffer and subjected 
to Western blot analysis utilizing affinity purified anti-PFK”anti~dy. 
To facilitate direct comparisons, pellets from centrifugation were resus- 
pended in a volume of homogenization buffer equal to that from which 
they were derived as described in section 2. Pane1 A demonstrates the 
decrease in the 8.5 kDa immunoreactive protein band in the supematant 
after 15 min of ischemia without reperfusion (panel A; O/O, 1 S/O). After 
15 min of ischemia followed by either 15 or 45 min of reperfuslon, the 
85 kDa immunoreactive protein band increased in intensity (panel A, 
15115, 15/45). Panel B demonstrates an increase in the 85 kDa Im- 
munoreactive protein band with 15 min ofischemia without reperfusion 
(panel B; O/O, 15/O). With either 15 or 45 min of reperfusion, the 85 kDa 
immunoreactive protein band decreases in intensity (panel B; 15115, 
15145). 
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ship between alterations in phospholipolysis and glycoly- 
sis in ischemic myocardium. 
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